Case Report
Copyright ©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 463-468
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.463
Figure 1
Figure 1 Visual Analogue Scores (0 = worst symptoms, 10 = no symptoms) were taken prior to administration of the dietary supplement (baseline) and at 2 wk end of analysis (end of analysis) for abdominal pain (A), bloating (B), and constipation (C). Each symbol represents a different, individual patient in the analysis.